Join the International Papillomavirus Society (IPVS)  for an in-depth discussion on the profound effects of HPV vaccination on transmission rates within populations. This webinar will explore both the molecular and epidemiological evidence supporting the impact of the HPV vaccine, shedding light on how these findings can be integrated into modeling frameworks to better understand its long-term impact.

Don’t miss out on this opportunity to gain valuable insights into how vaccination can shape public health strategies and drive progress in HPV prevention.

Moderators: Miquel Angel Pavón, PhD

Topics and Faculty:

1. HPV Vaccination Strategies and Their Impact on Population-Level HPV Transmission and Cervical Cancer Prevention - Hans Berkhof, PhD 2
2. Indirect Evidence and Clinical Trials Evaluating the Effect of HPV Vaccination on Direct Viral Transmission Between Individuals - Miriam Elfström, PhD 
3. Impact of HPV Vaccination on Neutralizing Antibodies and Viral Infectivity in Mucosal Sites - Miquel Angel Pavón, PhD

The objectives of this webinar are: 

1. Review the potential impact of including adults in HPV vaccination strategies aimed at cervical cancer prevention.
2. Assess indirect evidence and ongoing clinical trials to evaluate whether prophylactic HPV vaccines directly influence viral transmission. 
3. Discuss methodological approaches for evaluating the impact of vaccination on neutralizing antibody presence and viral particle infectivity in urine, cervical, anal, and oral mucosa.

This webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.5 European CME credits (ECMEC®s). This webinar will be recorded. If you have missed the previous IPVS webinars, you can watch the videos on demand on the IPVS members' website.